Cancer immunotherapy: Current applications and challenges

Cancer Lett. 2020 Jun 28:480:1-3. doi: 10.1016/j.canlet.2020.03.024. Epub 2020 Mar 27.

Authors

Jin-Yu Sun¹, Xiao-Jie Lu²

Affiliations

¹ Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Sparkfire Scientific Research Group, Nanjing Medical University, Nanjing, China.
² Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Sparkfire Scientific Research Group, Nanjing Medical University, Nanjing, China. Electronic address: 189@whu.edu.cn.

PMID: 32229188
DOI: 10.1016/j.canlet.2020.03.024

No abstract available

Publication types

Editorial
Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents, Immunological / pharmacology
Antineoplastic Agents, Immunological / therapeutic use
Clinical Trials as Topic
Humans
Immunotherapy / adverse effects
Immunotherapy / methods*
Neoplasms / immunology
Neoplasms / therapy*
Tumor Microenvironment / immunology

Substances

Antineoplastic Agents, Immunological